Drug Development and Registration

Aims & Scope

Research and production peer-reviewed journal «Drug development & registration» (Razrabotka i registraciâ lekarstvennyh sredstv) is an up-to-date quarterly free application publication and information portal for Professionals involved in the circulation of medicines.

Journal is designed for pharmaceutical manufacturers and their employees from the departments of development, quality control, registration, production and development; employees of laboratory centers, contract research organizations, scientific and educational institutions.

The main focus of the journal is to summarize scientific and practical achievements in the field of drug development and registration, to increase the scientific and practical qualifications of specialists in the field of drug circulation.

The main five thematic sections of the journal «Drug development & registration» (Razrabotka i registraciâ lekarstvennyh sredstv) include the development lifecycle of a drug product from its creation to obtaining a marketing authorization.

The first section is devoted to the research and development of new medicines, the second one provides information about pharmaceutical technology, pharmaceutical ingredients, and equipment for drug development.

The third section describes analytical quality control methods; the fourth section is devoted to approaches to evaluating the efficacy and safety of medicines, conducting clinical and preclinical studies.

The fifth section deals with the validation of methods, preparation of the registration dossier, the life cycle of the drug product in the GxP environment.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Health Professions and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Health Professions and Pharmacology, Toxicology and Pharmaceutics, ensuring accessibility and quality in research dissemination.

This journal does not charge a mandatory Article Processing Charge (APC). However, optional open access publication may incur fees based on the publisher’s policies.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Validation of Analytical Procedures: Graphic and Calculated Criteria for Assessment of Methods Linearity in Practice

  Citation: 17

  Authors: N. A.

• The Use of Ultrasound in the Extraction of Biologically Active Compounds from Plant Raw Materials, Used or promising for Use in Medicine (Review)

  Citation: 15

  Authors: A. A., N. N., A. I.

• <i>In situ</i> Intranasal Delivery Systems: Application Prospects and Main Pharmaceutical Aspects of Development (Review)

  Citation: 14

  Authors: E. O., N. B., M. M., P. S., D. S., I. I.

• Intranasal Administration as a Route to Deliver Drugs to the Brain (Review)

  Citation: 14

  Authors: N. N., I. I., R. I., V. V.

• Antimicrobial Activity of Polyphenolic Compounds

  Citation: 13

  Authors: V. G., A. K., A. O., V. V., E. A.

• Isolation of Individual Compounds from the Terrestrial Parts of Ononis Arvensis L. and Solidago Canadensis L.

  Citation: 11

  Authors: V. G., A. K., A. O., E. A., I. S., S. N., E. B.

• Choice of Extraction Method for Receiving Extraction from Seeds of Payne Hay with the High Content of Biologically Active Substances

  Citation: 10

  Authors: S. S., E. V., I. E.

• Ophthalmic Drug Delivery Systems (Review)

  Citation: 10

  Authors: E. O., M. N., N. B., I. V., A. R., I. I.

• Development and Validation of HPLC-UV Method for the Determination of Favipiravir in Human Plasma

  Citation: 9

  Authors: T. N., P. K., O. A., D. S., N. S., I. E., K. Ya., P. A.

• Phase I Pharmacokinetics Study of Drug «COVID-globulin» (Specific Human Immunoglobulin Against COVID-19)

  Citation: 9

  Authors: T. I., N. S., M. A., I. E., A. M., T. V., A. A., E. A.